公开(公告)号：EP2663322A4

公开(公告)日：2014-06-25

申请号：EP12734728

申请日：2012-01-12

申请人： SCYNEXIS INC

发明人： SCORNEAUX BERNARD ,  HOPKINS SAMUEL EARL ,  RIBEILL YVES JOSEPH

IPC分类号： A61K38/13 ,  A61P31/14

CPC分类号： A61K38/13 ,  A61K38/14 ,  C12Q1/707 ,  C12Q2600/106 ,  C12Q2600/156

摘要： Methods of predicting the response in a patient infected with hepatitis C virus (HCV) to a treatment regime involving the use of a cyclophilin-binding compound are described which provide for improvements in treatments, pharmaceutical compositions, dosing regimen, assays, kits, and other aspects of the art.